Umbilical endometriosis along with peritoneal endometriosis: a case report

Incidence of endometriosis is around 10 to 15% in women of reproductive age group. Umbilical endometriosis is a very rare entity. Extra genital endometriosis accounts to 3% of endometriosis. Incidence of umbilical endometriosis is 0.5%-4% of extra genital endometriosis. 30 years old multi gravida was referred to our hospital with c/o periodic bleeding from the umbilicus for the past 3 months. She was also having dysmenorrhoea for about 3 months. On examination, patient had a small bluish nodule in the umbilicus around 1.5x1.2 cm in size. Clinically there was suspicion of pelvic endometriosis as the uterus was retroverted and fixed. CT abdomen showed a small hypo-echoeic area in the umbilicus and uterus was adenomyotic with normal ovaries. Patient was given the option of laparoscopy and excision of umbilicus, as there was suspicion of peritoneal endometriosis and the patient also insisted upon laparoscopic sterilization. Laparoscopy showed early peritoneal endometriosis with pelvic adhesions and the same adhesiolysis was done along with cauterization of endometriosis. Sterilization was also done as per the patient’s request. Umbilical excision and layer closure was done. Umbilical endometriosis is a rare entity. This patient had associated early pelvic endometriosis. Umbilical endometriosis could be secondary to the lympho vascular spread from the pelvic endometriosis or primary umbilical endometriosis. History, clinical and imaging were pointing towards umbilical endometriosis. Surgical excision of umbilical endometriosis and cauterisation of early pelvic endometriosis were done. Patient needs follow up. Umbilical endometriosis may be primary or secondary which needs total excision and follow up

SPECTRO-ANALYTICAL, COMPUTATIONAL AND BIOLOGICAL STUDIES ON 4-PYRIDINE CARBOXALDEHYDE-3-HYDROXY-5-(HYDROXY METHYL)-2-METHYL HYDRAZONE HYDROCHLORIDE AND ITS CU (II) COMPLEXCA

Objective: The title compound 4-pyridine carboxaldehyde 3-hydroxy-5-(hydroxy methyl)-2-methyl hydrazone (PCHHMMH) hydrochloride an analogue of Pyridoxal isonicotinoyl hydrazone PIH, is an iron chelator. The PCHHMMH has potential donor sites suitable for metal ion binding, the study on structural aspects of the compound and its copper complex are explored. With a view to understand biological importance of title compounds, antimicrobial and cytotoxic studies were planned. Methods: In the present study the spectroanalytical techniques employed were pH-metry, spectrophotometry, IR, 1H & 13C-NMR, UV-Vis, ESR, Magnetic measurements, TGA and SEM. The computational method employed is HyperChem 7.5 software. The antimicrobial studies were carried out by agar disc diffusion method for antibacterial studies against Gram positive and Gram negative bacteria. The cytotoxic potential was measured by Sulforhodamine B (SRB) method against selected tumor cells. Results: The equilibrium studies by employing pH-metric method inferred the dissociation of two protons in it. Further titration in presence of Cu (II) ion, it is confirmed the release of two protons from title compound and formation of corresponding complex. The orientations of frontier orbitals for molecular and ionized forms of compound were computed to understand the electronic properties. The Cu (II) PCHHMMH complex was characterized by spectroanalytical methods and screened for, antimicrobial and cytotoxic activities. Conclusion: As the structural features are important to understand the chemical behavior of metal complexes, in the present study copper complex was synthesized and characterized by employing various spectro-analytical tools viz; IR, 1H & 13C-NMR, UV-Vis, ESR, Magnetic measurements, TGA and SEM. Further the antimicrobial and cytotoxic activities were evaluated and correlated with computed QSAR data

Mycogenesis of Gold Nanoparticles using a Phytopathogen Alternaria Alternata

The development of an eco-friendly and reliable process for the synthesis of gold nanomaterials (AuNPs) using microorganisms is gaining importance in the field of nanotechnology. In the present study, AuNPs have been synthesized by bio-reduction of chloroauric acid (HAuCl4) using the fungal culture filtrate (FCF) of Alternaria alternata. The synthesis of the AuNPs was monitored by UV–visible spectroscopy. The particles thereby obtained were characterized by UV, dynamic light scattering (DLS), X-ray diffraction (XRD), energy dispersive X-ray (EDX) analysis, Fourier transform infrared (FTIR) spectroscopy, atomic force microscopy (AFM) and transmission electron microscopy (TEM). Energy-dispersive X-ray study revealed the presence of gold in the nanoparticles. Fourier transform infrared spectroscopy confirmed the presence of a protein shell outside the nanoparticles which in turn also support their stabilization. Treatment of the fungal culture filtrate with aqueous Au? ions produced AuNPs with an average particle size of 12 ± 5 nm. This proposed mechanistic principal might serve as a set of design rule for the synthesis of nanostructures with desired architecture and can be amenable for the large scale commercial production and technical applications

Multi-gene testing in neurological disorders showed an improved diagnostic yield: data from over 1000 Indian patients

Background Neurological disorders are clinically heterogeneous group of disorders and are major causes of disability and death. Several of these disorders are caused due to genetic aberration. A precise and confirmatory diagnosis in the patients in a timely manner is essential for appropriate therapeutic and management strategies. Due to the complexity of the clinical presentations across various neurological disorders, arriving at an accurate diagnosis remains a challenge. Methods We sequenced 1012 unrelated patients from India with suspected neurological disorders, using TruSight One panel. Genetic variations were identified using the Strand NGS software and interpreted using the StrandOmics platform. Results We were able to detect mutations in 197 genes in 405 (40%) cases and 178 mutations were novel. The highest diagnostic rate was observed among patients with muscular dystrophy (64%) followed by leukodystrophy and ataxia (43%, each). In our cohort, 26% of the patients who received definitive diagnosis were primarily referred with complex neurological phenotypes with no suggestive diagnosis. In terms of mutations types, 62.8% were truncating and in addition, 13.4% were structural variants, which are also likely to cause loss of function. Conclusion In our study, we observed an improved performance of multi-gene panel testing, with an overall diagnostic yield of 40%. Furthermore, we show that NGS (next-generation sequencing)-based testing is comprehensive and can detect all types of variants including structural variants. It can be considered as a single-platform genetic test for neurological disorders that can provide a swift and definitive diagnosis in a cost-effective manner